Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference

Published: Monday, May 20, 2013
Last Updated: Monday, May 20, 2013
Bookmark and Share
The award, given to one product annually, recognizes the company’s development and introduction of the world’s most energy efficient ultra-low temperature freezer, the Stirling Ultracold SU780U.

The award was presented to Global Cooling’s CEO Neill Lane by ISBER President Katheryn E. Shea and Executive Officer Mark E. Sobel.

The award underscores the immediate impact on the $500 million ultra-low freezer industry associated with long-term storage of biologicals and other life forms in support of medical research, stem cell therapy, pharmaceutical development, drug discovery, environmental, life sciences, and biotechnology research. Ultra-low temperature storage requirements are increasing exponentially and an opportunity to dramatically reduce high energy and operating costs associated with this storage is now available. This 780 liter (27.5 cu. ft.) -80⁰C freezer offers users an array of new benefits while increasing safety, reliability, temperature performance and future viability of critical archived materials.

The Stirling Ultracold freezer is based on the industry’s first reliable ultra-low temperature cooling technology. The new freezer uses the Stirling Ultracold free-piston Stirling engine as an alternative to inefficient cascade refrigeration systems used in all competing products and offers unique sustainability benefits, using less than 20% of the refrigerant required by cascade systems. Unlike oil lubricated compressors, the Stirling engine operates with gas bearings which eliminate all wear. Independent customer tests confirm the value proposition and sustainability benefits assuring users that the Stirling Ultracold freezer offers unmatched temperature stability, better pull down from ambient, faster recovery following door openings, with lower operating and total life-cycle costs. This combination of energy efficiency and minimal use of refrigerants reduces the Stirling Ultracold carbon footprint to less than half that of any competing product.

The freezer and Stirling cooling engine are both manufactured in the United States at Global Cooling’s Athens, Ohio facility. In addition to the award-winning Model SU780U, Stirling Ultracold offers a range of unique Stirling cooled ultra-low temperature freezers including easily transportable Shuttle™ Model ULT-25N and the compact undercounter or benchtop SU105U freezer for small-volume storage.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Genetic Variability in Cell Bank Lots
Researchers working with cancer cells from the same cell bank acquired at the same time, found that the cells were genetically different.
Rapidly Generating Bone, Heart Muscle
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
New Mechanism of Tuberculosis Infection
Researchers have identified a new infection mechanism of tuberculosis that could lead to a new therapeutic angle.
Modelling ALS Requires ‘Aged’ Stem Cells
Research suggests engineered cells are too ‘young’ to accurately model ALS and should be 'aged' to speed progress toward finding potential treatments.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
HIV Hides No Longer
Researchers are working to create proteins that clear HIV-infected cells in order to eliminate latent infection and dormancy.
R&D Agreement for Development of CtDNA Diagnostics
SeraCare and NIST partner for development of ctDNA diagnostic assay reference materials.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!